Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arkadiusz Z Dudek

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|August 31, 2010
Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapyArkadiusz Z Dudek
Oncology (Williston Park, N.Y.)|July 20, 2016
Management of Resistance to EGFR TKI-Targeted Therapy of Lung Cancer: Lessons in Monitoring Cancer EvolutionArkadiusz Z Dudek
Anticancer Research|November 27, 2008
Safety of nab-paclitaxel plus sunitinib: analysis of three casesArkadiusz Z Dudek, Sheila Nguyen
Case Reports in Oncology|March 8, 2013
Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetamVarun Sreenivasan, Arkadiusz Z Dudek
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasisMani Keshtgarpour, Arkadiusz Z Dudek
Melanoma Research|May 4, 2011
Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trialsMing Chi, Arkadiusz Z Dudek
Current Opinion in Oncology|February 8, 2006
Hematopoietic stem cell transplant-related airflow obstructionArkadiusz Z Dudek, Hemchandra Mahaseth
Cancer Investigation|June 11, 2005
Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalArkadiusz Z Dudek, Hemchandra Mahaseth
Anticancer Research|July 31, 2013
Antineoplastic activity of zoledronic acid and denosumabPawel Zwolak, Arkadiusz Z Dudek
Anticancer Research|October 23, 2009
Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastasesSteven Powell, Arkadiusz Z Dudek
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Translational Research : the Journal of Laboratory and Clinical Medicine|August 31, 2010
Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapyArkadiusz Z Dudek
Oncology (Williston Park, N.Y.)|July 20, 2016
Management of Resistance to EGFR TKI-Targeted Therapy of Lung Cancer: Lessons in Monitoring Cancer EvolutionArkadiusz Z Dudek
Anticancer Research|November 27, 2008
Safety of nab-paclitaxel plus sunitinib: analysis of three casesArkadiusz Z Dudek, Sheila Nguyen
Case Reports in Oncology|March 8, 2013
Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetamVarun Sreenivasan, Arkadiusz Z Dudek
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasisMani Keshtgarpour, Arkadiusz Z Dudek
Melanoma Research|May 4, 2011
Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trialsMing Chi, Arkadiusz Z Dudek
Current Opinion in Oncology|February 8, 2006
Hematopoietic stem cell transplant-related airflow obstructionArkadiusz Z Dudek, Hemchandra Mahaseth
Cancer Investigation|June 11, 2005
Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalArkadiusz Z Dudek, Hemchandra Mahaseth
Anticancer Research|July 31, 2013
Antineoplastic activity of zoledronic acid and denosumabPawel Zwolak, Arkadiusz Z Dudek
Anticancer Research|October 23, 2009
Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastasesSteven Powell, Arkadiusz Z Dudek
Pageof 14